AwesomeCapital
Search This Blog
Tuesday, October 9, 2018
Wedbush Downgrades Arbutus Biopharma (ABUS) to Underperform
Wedbush analyst Robert Driscoll downgraded Arbutus Biopharma
https://www.streetinsider.com/Analyst+PT+Change/Wedbush+Downgrades+Arbutus+Biopharma+%28ABUS%29+to+Underperform/14686909.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.